Elderberry (Standardized).

Ascorbate regenerates oxidised elderberry anthocyanins so the polyphenol pool keeps working, and it concentrates in neutrophils where it supports their function. The two act at different points of the same response.

Zinc is required for thymulin activity, lymphocyte development and epithelial tight junctions, none of which elderberry supplies. The mineral covers the cellular side while the anthocyanins act on viral entry and cytokine tone.

Zinc acetate lozenges release ionic zinc onto the throat mucosa, a local effect distinct from elderberry's systemic anthocyanin metabolites. The two act in different compartments of the same response.

Calcitriol induces cathelicidin and defensin expression in respiratory epithelium, a mechanism separate from elderberry's flavonoid actions. The pathways do not overlap.

Echinacea alkylamides act on cannabinoid receptor 2 signalling in immune cells while elderberry anthocyanins act on viral surface binding and cytokine balance. The two mechanisms are distinct.

Quercetin acts as a zinc ionophore, moving zinc across cell membranes, and shares conjugation enzymes with elderberry anthocyanins so the two spare each other from rapid clearance. Both also stabilise mast cells.

Propolis contributes caffeic acid phenethyl ester and galangin, which act on local throat mucosa, while elderberry contributes anthocyanins acting systemically. The two polyphenol classes reach different sites.

Andrographolide dampens NF-kB driven cytokine expression while elderberry acts earlier, on viral surface binding. The two sit at separate stages of the same response.

NAC raises intracellular glutathione in airway epithelium and cleaves the disulfide bonds that make secretions thick. Elderberry contributes no sulfur amino acids, so the two cover separate parts of the airway response.

Elderberry anthocyanins and tannins bind ferric iron in the gut lumen and form complexes that are poorly absorbed. Separating an iron dose from a polyphenol-rich syrup by a couple of hours avoids the binding.

The catechol and galloyl groups on berry polyphenols chelate the non-heme iron in ferrous sulfate before it reaches the DMT1 transporter. This is the same mechanism by which tea lowers iron uptake from a meal.

Elderberry is standardised on cyanidin glycosides and bilberry on a wider set including delphinidin and malvidin. Combined, they raise total anthocyanin intake and widen the aglycone mix without adding a new mechanism. Both fractions are absorbed poorly as intact glycosides and are largely handled as microbial phenolic acid metabolites.

Rutin occurs naturally in elderberry alongside the anthocyanins, so an added rutin dose reinforces a constituent already present. Rutin is a rutinoside and needs gut bacterial rhamnosidase activity before the quercetin aglycone is absorbed. Read this as compositional overlap rather than a tested pairing.

Anthocyanin metabolites and resveratrol both pass through intestinal UGT and SULT conjugation on first pass. Given together they compete for that finite capacity, which can raise unconjugated levels of one or both. The competition is documented in enzyme and cell systems rather than in dosed human comparisons.

Both classes are largely converted by colonic bacteria to smaller phenolic acids such as protocatechuic and hydroxyphenylacetic acids, which is where much of the measurable systemic exposure comes from. Together they load the same microbial pathway. The shared catabolism is established; a combined clinical effect is not measured.

Grape seed proanthocyanidins and elderberry anthocyanins are frequently formulated together for a broader polyphenol profile. They share colonic conversion to phenolic acids and the same low intact bioavailability. The pairing is formulation convention supported by shared chemistry.

EGCG is a strong substrate and inhibitor of intestinal COMT, UGT and the efflux transporters that also handle anthocyanin metabolites. Combined, exposure to each is altered relative to either alone, in either direction depending on dose. Support comes from transporter and enzyme work, not from a human combination study.

Anthocyanins and the tannin-class polyphenols in a standardised elderberry extract form complexes with divalent cations in the gut lumen. That lowers the fraction of zinc available for uptake in the same sitting. Separating the doses by a couple of hours is the ordinary formulation answer.

The same catechol and galloyl groups that bind iron also complex copper. In a multivitamin taken with a polyphenol-rich extract, copper uptake in that meal is reduced. Anthocyanin-copper complexes are well characterised in solution chemistry.

Only a small percentage of ingested anthocyanin is absorbed intact; most is cleaved by colonic bacteria to phenolic acids that then enter circulation. The composition of that microbial community therefore sets how much metabolite a given dose yields. Which specific strains raise that yield in people has not been settled.

Inulin is fermented in the colon and supports the bacterial groups involved in polyphenol ring fission. That gives a mechanistic route for a prebiotic to change anthocyanin metabolite output. The step is plausible from fermentation biology; the size of the effect in people has not been quantified here.

FOS reaches the colon undigested and is fermented by the same bacterial groups implicated in polyphenol conversion. Formulators pair prebiotics with polyphenol extracts on this basis. The pairing rests on shared site of action rather than on a dosed combination result.

Lactoferrin sequesters free iron in the gut lumen, an unrelated mechanism to elderberry's anthocyanin chemistry, so the two do not overlap. They appear together in immune-support formulations. There is no combination study, so this sits at the level of formulation practice.

Yeast beta-glucan engages the dectin-1 receptor on innate immune cells, a route entirely separate from anthocyanin metabolism. Pairing them in a formula stacks two different mechanisms rather than doubling one. The receptor mechanism is well characterised in cell work; the pairing itself is not clinically tested.

Astragalus polysaccharides and elderberry anthocyanins appear together across botanical formulations aimed at normal immune function. The two constituent classes are chemically unrelated and there is no evidence of interference. Regard the pairing as convention, not measured synergy.

Tocopherol works in the lipid phase and anthocyanin metabolites in the aqueous phase, and phenolic compounds can regenerate the tocopheroxyl radical in model systems. That makes the pairing complementary in vitro. Whether it translates to a measurable effect in people from a supplemental dose is not established.

Piperine slows UGT-mediated conjugation in the gut wall, the main first-pass route for absorbed anthocyanin and its aglycones. In principle that raises circulating unconjugated metabolite levels. The mechanism is documented for several polyphenols but has not been dosed against an elderberry endpoint.

Anthocyanins hold their coloured flavylium form at acidic pH and shift toward colourless carbinol and chalcone forms as pH rises. An antacid dose of calcium carbonate raises gastric pH into that range. The chemistry is unambiguous even though the consequence for absorbed metabolite yield is not measured.